The US Food and Drug Administration approved Abbott Laboratories’ Patient Controller mobile device application that allows patients to control their implanted neuromodulation device with an Apple device instead of a separate, dedicated controller, the company announced 23 July.
Abbott is integrating the Patient Controller app with its NeuroSphere Digital Care connected care management platform. According to the company,...